| 1001 |
Asundexian versus Apixaban in Patients with Atrial Fibrillation
|
2024-09-27 |
714 |
| 1000 |
Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis The BASIS Randomized Clinical Trial
|
2024-09-27 |
559 |
| 999 |
Thrombectomy for Stroke With Large Infarct on Noncontrast CT : The TESLA Randomized Clinical Trial
|
2024-09-27 |
777 |
| 998 |
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core
|
2024-08-28 |
805 |
| 997 |
Efficacy and Safety of High-Dose TBS on Poststroke Upper Extremity Motor Impairment: A Randomized Controlled Trial
|
2024-08-28 |
801 |
| 996 |
Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial
|
2024-08-28 |
689 |
| 995 |
HERMES-24 Score Derivation and Validation for Simple and Robust Outcome Prediction After Large Vessel Occlusion Treatment
|
2024-07-30 |
776 |
| 994 |
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial
|
2024-07-30 |
779 |
| 993 |
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
|
2024-07-30 |
760 |
| 992 |
Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants
|
2024-07-01 |
830 |
| 991 |
Reteplase versus Alteplase for Acute Ischemic Stroke
|
2024-07-01 |
892 |
| 990 |
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia
|
2024-07-01 |
597 |
| 989 |
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial
|
2024-05-31 |
785 |
| 988 |
Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial
|
2024-05-31 |
610 |
| 987 |
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
|
2024-05-31 |
588 |
HOME
LOGIN
